tiprankstipranks
Opus Genetics, Inc. (IRD)
NASDAQ:IRD
US Market
IRD
Opus Genetics
RESEARCH TOOLSreports
Want to see IRD full AI Analyst Report?

Opus Genetics (IRD) Stock News & Sentiment

1,282 Followers
Opus Therapeutics: Buy Rating Reiterated on Advancing Gene Therapy Pipeline and Solid Cash Runway; $10 Price Target Maintained
Premium
Ratings
Opus Therapeutics: Buy Rating Reiterated on Advancing Gene Therapy Pipeline and Solid Cash Runway; $10 Price Target Maintained
3d ago
IRD
Occidental, ZoomInfo, GEHC, Opus, Medtronic Trending by Analysts
Premium
Weekend Updates
Occidental, ZoomInfo, GEHC, Opus, Medtronic Trending by Analysts
8d ago
GTM
IRD
IRD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IRD Upcoming Earnings Report: What to Expect?
25d ago
IRD
Avis, Travelers, Fifth Third, Opus, Lamb Weston Shock
Premium
Weekend Updates
Avis, Travelers, Fifth Third, Opus, Lamb Weston Shock
29d ago
LW
CAR
Opus Genetics Secures $155 Million Senior Note Financing
Premium
Company Announcements
Opus Genetics Secures $155 Million Senior Note Financing
1M ago
8K
IRD
Opus Genetics: Undervalued Gene Therapy Play on Upcoming Retinal Disease Data Catalysts
Premium
Ratings
Opus Genetics: Undervalued Gene Therapy Play on Upcoming Retinal Disease Data Catalysts
1M ago
IRD
Opus Genetics Shareholders Approve Governance and Capital Changes
Premium
Company Announcements
Opus Genetics Shareholders Approve Governance and Capital Changes
1M ago
8K
IRD
More IRD News >

IRD News on the Web

Opus Therapeutics: Buy Rating Reiterated on Advancing Gene Therapy Pipeline and Solid Cash Runway; $10 Price Target Maintained
TipRanks News
Bullish
Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst
MarketBeat
Bullish
Occidental, ZoomInfo, GEHC, Opus, Medtronic Trending by Analysts
TipRanks News
Bullish
Opus Genetics initiated with an Outperform at Leerink
TipRanks News
Bullish
Foundation Fighting Blindness Retinal Degeneration Fund Sells 1,700,000 Shares of Opus Genetics ...
GuruFocus News
Neutral
Major Stake in Opus Genetics Quietly Offloaded by Key Shareholder
TipRanks News
Neutral
Opus Genetics Inc at RBC Capital Markets Global Healthcare Conference Transcript
GuruFocus News
Neutral
LifeSci Capital Sticks to Its Buy Rating for Opus Genetics (IRD)
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
IRD
Sector Average
Media Buzz
This Week2 articles
Weekly Average6.5 articles
News Sentiment
This Week100%
Sector Average82%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IRD’s Media Buzz Sentiment?
2 articles about IRD were published this week. In an average week, 6.5 articles are published.
    What is IRD’s weekly average amount of articles?
    In an average week, 6.5 articles about IRD are published.
      What is IRD’s News Sentiment?
      100% of articles about IRD were positive this week, compared to its sector average of 82%.
        Healthcare Stocks that are Trending in the News
        AAgilent
        PHRPhreesia
        ADOAnteoTech Ltd
        OTLKOutlook Therapeutics
        IHHHFIHH Healthcare Bhd
        Showing the stocks with the most bullish news sentiment over the past week